|
|
| Article |
Antigens evaluated |
|
CD2 is expressed by a subpopulation of normal B cells and is frequently
present in mature B-cell neoplasms. |
CD2 |
|
Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin
lymphomas. |
CD2, CD4, CD7, CD8 |
|
Aberrant expression of
T-cell-associated markers CD4 and CD7 on B-cell
chronic lymphocytic leukemia. |
CD4, CD5, CD7, CD19, CD20, CD23, CD79b, FMC7, Kappa |
|
Aberrant expression of the CD8
antigen in B cell chronic lymphocytic leukaemia. |
CD3, CD5, CD8, CD19, CD20, CD23, CD45, IgM, Kappa,
Lambda |
|
B-cell chronic lymphocytic leukemia with aberrant CD8 expression: genetic
and immunophenotypic analysis of prognostic factors. |
CD5, CD8, CD19, CD20, CD23, Zap-70, 17p, 11q, 12 |
|
CD8+ chronic lymphocytic leukemia: an extensive characterization of a bizarre hybrid neoplasia. |
CD8, CD11c, CD56, CD154 |
|
Aberrant CD8 expression in B-chronic lymphocytic leukemia: report of five cases. |
CD5, CD8,
CD19, CD23, FMC-7 |
|
Aberrant CD8
antigen expression in a patient with B chronic
lymphocytic leukaemia showing unusual disease
progression. |
CD8 |
|
Low-grade B-cell
lymphoma with coexpression of both CD5 and CD10. A report of 3 cases. |
CD5, CD10 |
|
CD5-negative, CD10-negative small B-cell
leukemia: variant of chronic lymphocytic leukemia or a distinct entity? |
CD20, CD5, CD10, CD11c, CD23, CD25 |
|
Expression of CD10 by chronic lymphocytic leukemia cells undergoing
apoptosis in vivo and in vitro. |
CD5, CD10 |
|
Diagnostic significance of CD20 and FMC7 expression in B-cell disorders. |
CD20, FMC7 |
|
Transient down-modulation of CD20 by rituxamab in patients with chronic
lymphocytic leukemia. |
CD20 |
|
Diagnostic usefulness of aberrant CD22 expression in differentiating neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B cells in four-color multiparameter flow cytometry. |
CD22 |
|
Aberrant expression and
reverse signalling of CD70 on malignant B cells. |
CD27, CD40, CD70 |
|
Phenotypic heterogeneity of B cells
in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. |
|
|
